Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arterra Bioscience SpAMIL:ARBS -0.33%77 Days Inventory is 6,294.02 as of Dec. 2025, which is 1716% above its 10-year median of 346.55. GuruFocus rates MIL:ARBS with a GF Score™ of 77/100 and a GF Value™ of €2.91 (Fairly Valued). Among 638 Biotechnology companies, Arterra Bioscience SpA ranks worse than 94.2% on this metric.
The historical rank and industry rank for Arterra Bioscience SpA's Days Inventory or its related term are showing as below:
MIL:ARBS'
s Days Inventory Range Over the Past 10 Years
Min: 236.49 Med: 346.55 Max: 3299.04
Current: 1479.21
During the past 9 years, Arterra Bioscience SpA's highest Days Inventory was 3299.04. The lowest was 236.49. And the median was 346.55.
MIL:ARBS's Days Inventory is ranked worse than 94.2% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs MIL:ARBS: 1479.21
Arterra Bioscience SpA's Days Inventory
declined
from Dec. 2024 (11,096.00) to Dec. 2025 (6,294.02).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Arterra Bioscience SpA's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.03.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Arterra Bioscience SpA's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.67.
Arterra Bioscience SpA (MIL:ARBS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Arterra Bioscience SpA's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Arterra Bioscience SpA's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Arterra Bioscience SpA Days Inventory Related Terms
Arterra Bioscience SpA Days Inventory Historical Data
* Premium members only.
The historical data trend for Arterra Bioscience SpA's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:ARBS vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Arterra Bioscience SpA's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arterra Bioscience SpA Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Arterra Bioscience SpA's Days Inventory distribution charts can be found below:
* The bar in red indicates where Arterra Bioscience SpA's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arterra Bioscience SpA (MIL:ARBS) has a Days Inventory of 6,294.02 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Arterra Bioscience SpA and its competitors. This is 1716% above median its historical median of 346.55. Over the past decade, Arterra Bioscience SpA's Days Inventory has ranged from 236.49 to 3,299.04. According to the industry distribution chart, Arterra Bioscience SpA ranks #601 out of 638 companies in the Biotechnology industry, placing it in the top 94.2%.
Is Arterra Bioscience SpA's Days Inventory too high?
Arterra Bioscience SpA's current Days Inventory of 6,294.02 is 1716% above median its 10-year median of 346.55. Over the past 10 years, this metric has ranged from a low of 236.49 to a high of 3,299.04. The Biotechnology industry median Days Inventory is 183.20. Arterra Bioscience SpA's value of 6,294.02 is 3335.7% above this industry median. Based on the distribution chart, Arterra Bioscience SpA ranks #601 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Arterra Bioscience SpA has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Arterra Bioscience SpA's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Arterra Bioscience SpA ranks #601 out of 638 companies for Days Inventory. This places Arterra Bioscience SpA in the lower half of its industry. The industry median Days Inventory is 183.20. Arterra Bioscience SpA's value of 6,294.02 is 3335.7% above this benchmark. Historically, Arterra Bioscience SpA's own Days Inventory has ranged from 236.49 to 3,299.04 over the past decade. While the company's 10-year median is 346.55 vs. the industry median of 183.20, Arterra Bioscience SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arterra Bioscience SpA's current Days Inventory of 6,294.02 is 3335.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Arterra Bioscience SpA and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arterra Bioscience SpA's current Days Inventory is 6,294.02, which is 1716% above median its own 10-year median of 346.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arterra Bioscience SpA stock overvalued right now?
Based on GuruFocus' analysis, Arterra Bioscience SpA (MIL:ARBS) is currently considered Fairly Valued. The stock's GF Value™ is €2.91, compared to a current price of €3.04 — trading 4.5% above its estimated fair value. The current Days Inventory is 6,294.02, which is 1716% above median its 10-year median of 346.55 and 3335.7% above the Biotechnology industry median of 183.20. Arterra Bioscience SpA's overall GF Score™ is 77/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Arterra Bioscience SpA (MIL:ARBS), the current Days Inventory is 6,294.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arterra Bioscience SpA (MIL:ARBS) Overvalued in 2026?
Based on GuruFocus' analysis, Arterra Bioscience SpA stock appears to be overvalued.
The current stock price of €3.04 is trading 4.5% above its estimated GF Value™ of €2.91.
GuruFocus considers Arterra Bioscience SpA to be Fairly Valued.
Key valuation signals for MIL:ARBS:
Days Inventory: 6,294.02 (1716% above median its 10-year median of 346.55)
GF Value™: €2.91 vs. price of €3.04 (4.5% above fair value)
Industry Position: 3335.7% above the Biotechnology median (#601 of 638)
No single metric tells the full story. See the MIL:ARBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.
77GF Score
Get the complete analysis for MIL:ARBS
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:ARBS has been successfully added to your 
